Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 29 | 2018 | 961 | 4.740 |
Why?
|
| Sexually Transmitted Diseases | 12 | 2014 | 109 | 1.830 |
Why?
|
| Patient Acceptance of Health Care | 9 | 2017 | 292 | 1.530 |
Why?
|
| South Africa | 17 | 2018 | 61 | 1.480 |
Why?
|
| Rural Population | 10 | 2018 | 170 | 1.430 |
Why?
|
| Reagent Kits, Diagnostic | 3 | 2016 | 38 | 1.310 |
Why?
|
| Community Networks | 5 | 2017 | 32 | 1.040 |
Why?
|
| Self Care | 4 | 2016 | 167 | 1.020 |
Why?
|
| Brazil | 19 | 2015 | 81 | 1.000 |
Why?
|
| Sexual Behavior | 8 | 2015 | 328 | 0.950 |
Why?
|
| Sexual Partners | 7 | 2018 | 106 | 0.870 |
Why?
|
| Social Environment | 5 | 2013 | 194 | 0.830 |
Why?
|
| Homosexuality, Male | 4 | 2016 | 332 | 0.830 |
Why?
|
| Social Stigma | 4 | 2017 | 86 | 0.830 |
Why?
|
| AIDS Serodiagnosis | 4 | 2017 | 27 | 0.790 |
Why?
|
| Unsafe Sex | 4 | 2012 | 45 | 0.760 |
Why?
|
| Sex Workers | 2 | 2013 | 9 | 0.760 |
Why?
|
| Health Services Accessibility | 3 | 2016 | 481 | 0.740 |
Why?
|
| Condoms | 5 | 2015 | 38 | 0.740 |
Why?
|
| Mass Screening | 4 | 2017 | 696 | 0.720 |
Why?
|
| Health Promotion | 4 | 2017 | 170 | 0.690 |
Why?
|
| Community Health Services | 3 | 2017 | 81 | 0.680 |
Why?
|
| Program Evaluation | 2 | 2014 | 315 | 0.670 |
Why?
|
| Sex Work | 5 | 2012 | 12 | 0.630 |
Why?
|
| Interviews as Topic | 9 | 2017 | 364 | 0.610 |
Why?
|
| Risk-Taking | 5 | 2018 | 158 | 0.580 |
Why?
|
| Adolescent | 23 | 2018 | 9606 | 0.560 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2017 | 557 | 0.550 |
Why?
|
| Counseling | 3 | 2017 | 168 | 0.510 |
Why?
|
| Adult | 32 | 2018 | 27918 | 0.500 |
Why?
|
| Young Adult | 20 | 2017 | 6930 | 0.490 |
Why?
|
| Behavior Rating Scale | 1 | 2016 | 5 | 0.490 |
Why?
|
| Community Participation | 1 | 2016 | 38 | 0.470 |
Why?
|
| Anti-Retroviral Agents | 1 | 2016 | 35 | 0.470 |
Why?
|
| Male | 31 | 2018 | 44557 | 0.470 |
Why?
|
| Text Messaging | 1 | 2016 | 35 | 0.460 |
Why?
|
| Continuity of Patient Care | 2 | 2017 | 176 | 0.460 |
Why?
|
| Clinical Protocols | 1 | 2016 | 154 | 0.450 |
Why?
|
| Patient Dropouts | 1 | 2015 | 31 | 0.450 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2015 | 73 | 0.440 |
Why?
|
| Bisexuality | 1 | 2015 | 36 | 0.440 |
Why?
|
| Psychometrics | 1 | 2016 | 337 | 0.430 |
Why?
|
| Humans | 48 | 2018 | 93515 | 0.420 |
Why?
|
| Ambulatory Care Facilities | 1 | 2015 | 117 | 0.420 |
Why?
|
| Transgender Persons | 1 | 2016 | 113 | 0.420 |
Why?
|
| Preventive Health Services | 1 | 2014 | 38 | 0.420 |
Why?
|
| Masculinity | 1 | 2013 | 17 | 0.410 |
Why?
|
| Surveys and Questionnaires | 9 | 2017 | 2802 | 0.400 |
Why?
|
| Domestic Violence | 1 | 2013 | 25 | 0.400 |
Why?
|
| Social Participation | 1 | 2013 | 16 | 0.390 |
Why?
|
| Health Personnel | 1 | 2015 | 234 | 0.380 |
Why?
|
| Adolescent Health Services | 1 | 2012 | 13 | 0.370 |
Why?
|
| San Francisco | 5 | 2016 | 25 | 0.360 |
Why?
|
| Self-Examination | 2 | 2013 | 5 | 0.360 |
Why?
|
| Reproductive Health Services | 1 | 2012 | 20 | 0.360 |
Why?
|
| Socioeconomic Factors | 9 | 2016 | 624 | 0.360 |
Why?
|
| Female | 29 | 2018 | 48702 | 0.350 |
Why?
|
| Patient Compliance | 2 | 2017 | 237 | 0.350 |
Why?
|
| Attitude | 1 | 2012 | 132 | 0.340 |
Why?
|
| Patient Preference | 1 | 2012 | 125 | 0.330 |
Why?
|
| Global Health | 2 | 2013 | 208 | 0.320 |
Why?
|
| Models, Statistical | 2 | 2010 | 585 | 0.310 |
Why?
|
| Probability | 1 | 2010 | 355 | 0.300 |
Why?
|
| Papillomaviridae | 1 | 2010 | 179 | 0.290 |
Why?
|
| Substance-Related Disorders | 1 | 2013 | 441 | 0.280 |
Why?
|
| Focus Groups | 3 | 2016 | 184 | 0.280 |
Why?
|
| Motor Vehicles | 1 | 2007 | 19 | 0.260 |
Why?
|
| Health Services Administration | 1 | 2007 | 2 | 0.260 |
Why?
|
| Vaginal Smears | 1 | 2007 | 71 | 0.260 |
Why?
|
| Travel | 1 | 2007 | 73 | 0.250 |
Why?
|
| Occupational Diseases | 1 | 2007 | 53 | 0.250 |
Why?
|
| Health Services | 1 | 2007 | 56 | 0.250 |
Why?
|
| Cross-Sectional Studies | 7 | 2017 | 1847 | 0.250 |
Why?
|
| International Cooperation | 1 | 2007 | 133 | 0.250 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2010 | 318 | 0.250 |
Why?
|
| Papillomavirus Infections | 1 | 2010 | 300 | 0.240 |
Why?
|
| Pilot Projects | 4 | 2016 | 917 | 0.240 |
Why?
|
| Middle Aged | 12 | 2017 | 27573 | 0.240 |
Why?
|
| Qualitative Research | 3 | 2017 | 347 | 0.230 |
Why?
|
| Herpes Genitalis | 2 | 2015 | 8 | 0.200 |
Why?
|
| Quality Assurance, Health Care | 2 | 2015 | 225 | 0.200 |
Why?
|
| Residence Characteristics | 4 | 2015 | 212 | 0.200 |
Why?
|
| Prejudice | 2 | 2016 | 49 | 0.180 |
Why?
|
| Alcohol Drinking | 2 | 2015 | 283 | 0.180 |
Why?
|
| Sex Factors | 2 | 2017 | 1105 | 0.180 |
Why?
|
| Cluster Analysis | 2 | 2017 | 391 | 0.180 |
Why?
|
| Pain | 1 | 2003 | 414 | 0.170 |
Why?
|
| HIV-1 | 2 | 2014 | 173 | 0.160 |
Why?
|
| Trichomonas vaginalis | 2 | 2013 | 3 | 0.160 |
Why?
|
| Risk Factors | 7 | 2016 | 5899 | 0.160 |
Why?
|
| Leiomyoma | 1 | 2003 | 211 | 0.160 |
Why?
|
| Perception | 2 | 2017 | 179 | 0.150 |
Why?
|
| Uterine Neoplasms | 1 | 2003 | 277 | 0.150 |
Why?
|
| Early Diagnosis | 2 | 2017 | 135 | 0.140 |
Why?
|
| Poverty | 2 | 2012 | 193 | 0.140 |
Why?
|
| Herpesvirus 2, Human | 2 | 2015 | 20 | 0.140 |
Why?
|
| Intimate Partner Violence | 1 | 2018 | 33 | 0.130 |
Why?
|
| Prevalence | 5 | 2018 | 1321 | 0.130 |
Why?
|
| Rural Health | 1 | 2017 | 18 | 0.130 |
Why?
|
| Feasibility Studies | 2 | 2016 | 756 | 0.130 |
Why?
|
| HIV Seroprevalence | 1 | 2016 | 9 | 0.120 |
Why?
|
| Alcoholism | 1 | 2018 | 188 | 0.120 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2016 | 73 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 2 | 2009 | 894 | 0.120 |
Why?
|
| Public Facilities | 1 | 2016 | 1 | 0.120 |
Why?
|
| Attitude to Health | 1 | 2017 | 217 | 0.120 |
Why?
|
| Medication Adherence | 1 | 2017 | 122 | 0.120 |
Why?
|
| Poverty Areas | 2 | 2014 | 37 | 0.120 |
Why?
|
| Social Control, Informal | 1 | 2015 | 5 | 0.110 |
Why?
|
| Sample Size | 1 | 2016 | 128 | 0.110 |
Why?
|
| Costs and Cost Analysis | 1 | 2016 | 154 | 0.110 |
Why?
|
| Alcoholic Beverages | 1 | 2015 | 12 | 0.110 |
Why?
|
| Life Change Events | 1 | 2015 | 46 | 0.110 |
Why?
|
| South America | 1 | 2015 | 36 | 0.110 |
Why?
|
| Social Support | 2 | 2015 | 233 | 0.110 |
Why?
|
| Social Perception | 1 | 2016 | 92 | 0.110 |
Why?
|
| Stress, Psychological | 1 | 2018 | 342 | 0.110 |
Why?
|
| Laboratory Proficiency Testing | 1 | 2014 | 5 | 0.110 |
Why?
|
| Program Development | 1 | 2015 | 131 | 0.110 |
Why?
|
| Blood | 1 | 2014 | 68 | 0.110 |
Why?
|
| Shame | 1 | 2014 | 3 | 0.110 |
Why?
|
| North America | 1 | 2015 | 195 | 0.110 |
Why?
|
| Data Collection | 1 | 2016 | 370 | 0.110 |
Why?
|
| Urban Population | 2 | 2014 | 234 | 0.110 |
Why?
|
| Veterans | 1 | 2015 | 99 | 0.100 |
Why?
|
| Health Surveys | 3 | 2014 | 241 | 0.100 |
Why?
|
| Viral Load | 1 | 2014 | 154 | 0.100 |
Why?
|
| Regression Analysis | 3 | 2010 | 579 | 0.100 |
Why?
|
| Military Personnel | 1 | 2015 | 104 | 0.100 |
Why?
|
| Heterosexuality | 1 | 2013 | 20 | 0.100 |
Why?
|
| Social Marginalization | 1 | 2013 | 3 | 0.100 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2013 | 67 | 0.100 |
Why?
|
| Trichomonas Vaginitis | 1 | 2013 | 1 | 0.100 |
Why?
|
| Parasitology | 1 | 2013 | 2 | 0.100 |
Why?
|
| Gonorrhea | 2 | 2010 | 23 | 0.100 |
Why?
|
| Chlamydia Infections | 2 | 2010 | 29 | 0.100 |
Why?
|
| Health Education | 1 | 2013 | 105 | 0.100 |
Why?
|
| Men's Health | 1 | 2012 | 5 | 0.090 |
Why?
|
| Self Efficacy | 1 | 2012 | 58 | 0.090 |
Why?
|
| Confidentiality | 1 | 2012 | 75 | 0.090 |
Why?
|
| Safe Sex | 1 | 2012 | 24 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2715 | 0.090 |
Why?
|
| Point-of-Care Systems | 1 | 2013 | 150 | 0.090 |
Why?
|
| Crime Victims | 1 | 2012 | 55 | 0.090 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 452 | 0.080 |
Why?
|
| Hepatitis B | 1 | 2011 | 77 | 0.080 |
Why?
|
| Longitudinal Studies | 2 | 2015 | 1161 | 0.080 |
Why?
|
| Violence | 1 | 2012 | 152 | 0.080 |
Why?
|
| Logistic Models | 5 | 2014 | 1243 | 0.080 |
Why?
|
| Multivariate Analysis | 3 | 2014 | 985 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 660 | 0.080 |
Why?
|
| Social Identification | 1 | 2010 | 27 | 0.080 |
Why?
|
| Cervix Uteri | 1 | 2010 | 73 | 0.080 |
Why?
|
| Antibodies, Viral | 1 | 2011 | 322 | 0.080 |
Why?
|
| Self Disclosure | 1 | 2008 | 29 | 0.070 |
Why?
|
| Computers | 1 | 2008 | 102 | 0.070 |
Why?
|
| Stereotyping | 1 | 2008 | 16 | 0.070 |
Why?
|
| Computing Methodologies | 1 | 2008 | 8 | 0.070 |
Why?
|
| Health Status | 1 | 2010 | 377 | 0.070 |
Why?
|
| Truth Disclosure | 1 | 2008 | 73 | 0.070 |
Why?
|
| Permissiveness | 1 | 2007 | 1 | 0.070 |
Why?
|
| DNA, Protozoan | 1 | 2007 | 15 | 0.070 |
Why?
|
| Chlamydia trachomatis | 1 | 2007 | 14 | 0.070 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2007 | 17 | 0.070 |
Why?
|
| Italy | 2 | 2003 | 110 | 0.060 |
Why?
|
| Gender Identity | 2 | 2018 | 58 | 0.060 |
Why?
|
| DNA, Bacterial | 1 | 2007 | 232 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2013 | 3054 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2007 | 711 | 0.060 |
Why?
|
| Commerce | 2 | 2015 | 29 | 0.060 |
Why?
|
| Pain, Intractable | 1 | 2003 | 8 | 0.050 |
Why?
|
| Premenopause | 1 | 2003 | 63 | 0.050 |
Why?
|
| Dyspareunia | 1 | 2003 | 23 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2012 | 4560 | 0.050 |
Why?
|
| Postmenopause | 1 | 2003 | 106 | 0.050 |
Why?
|
| Dysmenorrhea | 1 | 2003 | 59 | 0.050 |
Why?
|
| Polychlorinated Dibenzodioxins | 1 | 2002 | 4 | 0.050 |
Why?
|
| Menstrual Cycle | 1 | 2002 | 59 | 0.050 |
Why?
|
| Environmental Pollutants | 1 | 2002 | 56 | 0.040 |
Why?
|
| Contact Tracing | 2 | 2014 | 29 | 0.040 |
Why?
|
| Environmental Exposure | 1 | 2002 | 355 | 0.040 |
Why?
|
| Baths | 1 | 2016 | 10 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2016 | 13 | 0.030 |
Why?
|
| Afghan Campaign 2001- | 1 | 2015 | 5 | 0.030 |
Why?
|
| Iraq War, 2003-2011 | 1 | 2015 | 5 | 0.030 |
Why?
|
| Peru | 1 | 2015 | 28 | 0.030 |
Why?
|
| California | 1 | 2015 | 158 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2014 | 285 | 0.030 |
Why?
|
| Social Conditions | 1 | 2012 | 8 | 0.020 |
Why?
|
| Multilevel Analysis | 1 | 2012 | 25 | 0.020 |
Why?
|
| New York City | 1 | 2012 | 69 | 0.020 |
Why?
|
| Social Values | 1 | 2012 | 44 | 0.020 |
Why?
|
| Propensity Score | 1 | 2012 | 178 | 0.020 |
Why?
|
| Seroepidemiologic Studies | 1 | 2011 | 56 | 0.020 |
Why?
|
| Research Design | 1 | 2015 | 617 | 0.020 |
Why?
|
| Hepatitis B virus | 1 | 2011 | 47 | 0.020 |
Why?
|
| Syphilis | 1 | 2011 | 35 | 0.020 |
Why?
|
| Population | 1 | 2010 | 36 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 60 | 0.020 |
Why?
|
| Social Desirability | 1 | 2010 | 12 | 0.020 |
Why?
|
| Social Change | 1 | 2010 | 9 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2010 | 256 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2011 | 464 | 0.020 |
Why?
|
| Linear Models | 1 | 2010 | 413 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 1922 | 0.020 |
Why?
|
| Transportation | 1 | 2008 | 20 | 0.020 |
Why?
|
| Trichomonas Infections | 1 | 2008 | 1 | 0.020 |
Why?
|
| Emigration and Immigration | 1 | 2008 | 49 | 0.020 |
Why?
|
| Bias | 1 | 2008 | 137 | 0.020 |
Why?
|
| Social Isolation | 1 | 2008 | 71 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2011 | 378 | 0.020 |
Why?
|
| Animals | 1 | 2007 | 28155 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2008 | 170 | 0.020 |
Why?
|
| Chemical Industry | 1 | 2002 | 1 | 0.010 |
Why?
|
| Explosions | 1 | 2002 | 8 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 9099 | 0.010 |
Why?
|
| Biomarkers | 1 | 2008 | 1910 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2002 | 3830 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 20434 | 0.010 |
Why?
|